Salud y calidad de vida

Two-phase composition for use in maintaining proper psychological functions and preventing neurodegenerative processes
07/09/2026 - Przedmiotem zgłoszenia jest dwufazowa kompozycja, która zawiera związki polifenolowe, w tym antocyjany pochodzące głównie z mieszaniny soków z owoców jagodowych występujących w postaci...
NANOPARTICLE-DECORATED CELLS AND USE THEREOF
10/09/2026 - Nanoconjugates comprising myeloid-derived suppressor cells conjugated to nanoparticles optionally encapsulating therapeutic agents, nanoparticles comprising poly( lactic-co-glycolic acid),...
COMPOSITION COMPRISING A NON-VIABLE MICROORGANISM
10/09/2026 - A composition comprising inanimate lactic acid bacteria and their fermentation components conferring health benefits is disclosed.
CRYSTALLINE FORM OF SUBSTITUTED BENZOIMIDIZOLE COMPOUND
10/09/2026 - The present application relates to solid forms of N-(1-(tert-butyl)-6-cyano-4,7-difluoro- 1H-benzo[d]imidazole-2-yl)-3,3-dimethylbutanamide (I) pharmaceutical compositions and methods of use...
HETEROCYCLIC COMPOUNDS THAT INHIBIT TYROSINE KINASE 2 (TYK2) ACTIVITY
10/09/2026 - The present disclosure relates to heterocyclic compounds suitable for inhibiting or regulating the activity of tyrosine kinase 2 (TYK2). Specifically, the present disclosure relates to compounds...
Treatment of Inflammation in the Central Nervous System
10/09/2026 - The present invention pertains to the anti-inflammatory therapeutic effect of xantohumol in spinal cord injury (SCI). The continuous administration of xanthohumol for 1-8 weeks to SCI rats...
PATIENT INJURY PREVENTION SYSTEMS, METHODS, AND DEVICES
27/08/2026 - Systems, methods, and devices to reduce occurrence of adverse health events in a patient are disclosed. A patient injury prevention system operable to receive medical records for a patient of from...
SYSTEMS AND METHODS FOR PREDICTING HEART DISEASE EVENTS
27/08/2026 - Systems, methods, and computer-readable media are disclosed for predicting heart disease events using multimodal biometric and clinical data processed by a temporally-aware machine learning model....
TESTING ORAL HEALTH DEVICE EFFICACY
27/08/2026 - Methods and systems to analyze the efficacy of an oral health device. The method includes impinging an efficacy media with an output of the oral health device. Then, analyzing the impinged...
PREDICTING A TREATABLE HUNTINGTON'S DISEASE PATIENT/PATIENT POPULATION AND EFFECTS ON DISEASE PROGRESSION FOR THERAPIES TARGETING SOMATIC INSTABILITY
27/08/2026 - Somatic instability (SI) in the mutant HTT allele is a high value therapeutic target for Huntington's Disease (HD). However, rates of SI and the speed of HD progression vary widely with inherited...
PATHOLOGICAL TAU PROTEIN OBTAINED BY MEANS OF MULTI-ROUND AMPLIFICATION, PREPARATION METHOD THEREFOR AND USE THEREOF
27/08/2026 - Disclosed is a preparation technical method capable of preparing a large number of pathogenic tau proteins having a pathological conformation similar to that in the brain of a patient with...
HEALTH FUNCTIONAL FOOD WITH BLOOD SUGAR AND BLOOD PRESSURE LOWERING EFFECTS
26/08/2026 - 본 발명은 천연 추출물을 포함하는 혈당 및 혈압 강하용 조성물 및 혈당 및 혈압 강하 효능을 갖는 건강기능식품에 관한 것이다. 본 발명은 혈당 및...
Method of Treating Cancer
10/09/2026 - A method to enhance immune checkpoint blockade in breast cancer and other solid tumors and hematologic tumors by administering a PD-1/PD-L1 inhibitor together with branched-chain amino acids...
Anti-human integrin alpha3/Beta1 antibodies and methods of use therefor
10/09/2026 - [0000] Disclosed is a monoclonal antibody, MAb51-31 mAb, and its fragments and derivatives that recognize a conformational epitope of human integrin α3/β1 (ITGα3/β1) complex, which is...
ENGINEERED IGA ANTI-EPITHELIAL CELL ADHESION MOLECULE
10/09/2026 - Provided herein are engineered IgA antibodies that comprises: (a) an EPCAM binding domain and (b) an IgA heavy chain constant region. Also, provided herein are methods of treating cancer in a...
DELIVERY OF PROTEIN EXTRACELLULARLY
10/09/2026 - The described technology pertains to biotechnology, specifically engineered bacterial systems designed for extracellular delivery of therapeutic proteins in cancer treatment. The disclosed...
USE OF BAIAP2 INHIBITORS SUCH AS SUBSTITUTED PHENAZINES TO TREAT CANCER
10/09/2026 - Disclosed are small molecule inhibitors useful in reducing or ameliorating the proliferation and migration of cancer. Pharmaceutical compositions containing the small molecule inhibitors are also...
HETEROCYCLIC COMPOUNDS THAT INHIBIT TYROSINE KINASE 2 (TYK2) ACTIVITY
10/09/2026 - The present disclosure relates to heterocyclic compounds suitable for inhibiting or regulating the activity of tyrosine kinase 2 (TYK2). Specifically, the present disclosure relates to compounds...
TARGETING OF SIALYL TN-EXPRESSING SOLID TUMORS
10/09/2026 - The present disclosure provides two STn targeting units derived from two antibodies AM51.1 and AM52.1. Immunoreactivity of AM51.1 and AM52.1 was only detected in epithelial tumor tissues, while no...
COMBINATION THERAPIES FOR TREATING CANCER
10/09/2026 - Provided are methods of treating cancer that comprise administering a polypeptide (e.g. a fusion polypeptide) that comprises a SIRPα D1 domain variant and an Fc domain variant in combination with...
USE OF BAIAP2 INHIBITORS SUCH AS SUBSTITUTED PHENAZINES TO TREAT CANCER
10/09/2026 - Disclosed are small molecule inhibitors useful in reducing or ameliorating the proliferation and migration of cancer. Pharmaceutical compositions containing the small molecule inhibitors are also...